BioSpace News Archive

Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the second quarter of 2023.

Arcturus Therapeutics Holdings Inc. (the “Company,” “Arcturus,” Nasdaq: ARCT) today announced its financial results for the second quarter and six months ended June 30, 2023 and provided corporate updates.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal third quarter ended June 30, 2023.

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended June 30, 2023.

180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that an agreement has been reached with Prof. Avi Domb of the Hebrew University, School of Pharmacy, and with Prof. Elyad Davidson, of Hadassah Hospital, to perform a clinical pharmacology (“Pharmacokinetic” or “PK”) study of the uptake of cannabidiol (CBD) in a formulation which can be delivered as a pill orally.

NS Pharma, Inc. announced today the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to NS-089/NCNP-02, an investigational candidate for patients with Duchenne muscular dystrophy amenable to exon 44 skipping therapy.

Poseida Therapeutics Announces Strategic Investment by Astellas and Provides Business Update.

Hospital for Special Surgery, the world’s leading academic medical center specialized in musculoskeletal health, announced the appointment of Answorth A. Allen, MD, and Mathias P. Bostrom, MD, as Associate Surgeons-in-Chief.

Worldwide Clinical Trials (“Worldwide” or the “Company”) announced today that an affiliate of Kohlberg & Company, LLC (“Kohlberg”), a leading private equity firm with over 35 years of experience partnering with management and companies like Worldwide, has entered into a definitive agreement to acquire the Company.

Iron Path Capital (“Iron Path”), a private equity firm focused on healthcare and specialty industrials, is pleased to announce its partnership with Aldon Corporation (“Aldon”), a leading private-label manufacturer and distributor to the healthcare, life science and STEM education end markets.